Nigeria launches campaign to protect more than 28 million children against Measles and Meningitis
Children in 19 Northern states to be vaccinated in largescale campaign implemented by the Government of Nigeria and WHO with Gavi support
Abuja, 16 November 2019 - In efforts to continue boosting the immunity of children against measles and meningitis, Government, through the National Primary Health Care Development Agency (NPHCDA) and the World Health Organization (WHO), with support from Gavi, the Vaccine Alliance, today kicks off a campaign to reach more than 28 million children with lifesaving vaccines.
They will be vaccinated across 19 Northern states, namely: Bauchi, Benue, Borno, Kano, Katsina, Plateau, Taraba, Niger, Adamawa, Kaduna and Sokoto. Others are Gombe Jigawa, Kebbi, Nasarawa, Yobe, Zamfara, Kwara and the Federal Capital Territory.
Speaking on preparations for the campaign, Dr Joseph Oteri, Director of Disease Control and Immunization, NPHCDA said,
“Measles is a highly contagious respiratory viral disease with increased mortality and morbidity in children under five years, and Nigeria has experienced repeated outbreaks of measles in recent years due to low routine immunization coverage. In addition, Nigeria is within the meningitis belt, where the incidence rate is very high, especially in the North”.
He further stated, “Government is committed to ensuring every eligible child is reached with these lifesaving vaccines. We will go to markets, schools, churches, mosques and everywhere we can get good catchment to reach our target population. No child deserves to die from any vaccine preventable disease.”
“Gavi is committed to supporting Nigeria in achieving its goal of improved immunisation coverage. Diseases like measles are both devastating and easily preventable – more than 21 million lives around the world have been saved with the measles vaccine,” said Thabani Maphosa, Gavi Country Programmes Managing Director. “Furthermore, with so many Nigerians at risk from meningitis every year, immunisation with the MenA vaccine can help to limit outbreaks. Gavi’s work vaccinating more than 279 million children in Africa’s meningitis belt has shown the ability of the vaccine to reduce prevalence of the disease.”
Gavi is supporting the Government of Nigeria by funding measles and MenA vaccines, as well as operational costs for these campaigns. These resources are provided for integrated MenA and Measles campaigns in 17 states and in Kano (Measles and MenA stand-alone), Yobe (Measles) and five other southern states (e.g., Oyo, Imo, Cross River, Eboyni and Anambra) that are planning MenA campaigns in December 2019.
For its part, WHO Nigeria has trained over 44,000 health workers and is mobilizing over 17,000 vaccination teams to support these campaigns.
Dr Fiona Braka, the WHO Team Lead of the Expanded Programme on Immunization (EPI) reiterated that, “The measles vaccine remains the most cost effective preventive measure against measles and WHO is committed to supporting the Nigerian government in reaching every eligible child in the country with the needed vaccines irrespective of their location.”
Note to editors:
Measles is a highly contagious viral disease. It remains an important cause of death among young children globally, despite the availability of a safe and effective vaccine.
Under the Global Vaccine Action Plan, measles and rubella are targeted for elimination in five WHO Regions by 2020. WHO is the lead technical agency responsible for coordination of immunization and surveillance activities supporting all countries to achieve this goal.
Anne Eudes Jean Baptiste; Email: jeana [at] who.int. Tel: +234 813 173 6281